Work

Is there a need for emerging drugs for the acute respiratory distress syndrome?

Year: 2014

Type: editorial

Abstract: The acute respiratory distress syndrome (ARDS) is a common and devastating syndrome of acute respiratory failure for which little effective pharmacotherapy exists. The authors describe some interventions that show promise as potential therapies for this condition, with particular reference to clinically relevant human models of ARDS. Aspirin, mesenchymal stromal (stem) cells, keratinocyte growth factor, IFN-β and oncostatin M inhibition are discussed.

Source: Expert Opinion on Emerging Drugs

DOI: 10.1517/14728214.2014.953052

Authors: Marianne Fitzgerald, Daniel F McAuley, Michael Matthay

Institutions: Queen's University Belfast, University of San Francisco

Language: English

Topic: Respiratory Support and Mechanisms

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Public Health Agency, Medical Research Council, National Heart, Lung, and Blood Institute